Skip to content
lifestyle.entreprenerd.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
iBio, Inc.
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
September 1, 2026
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
August 28, 2026
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
August 4, 2026
iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
July 1, 2026
iBio to Participate in Upcoming Healthcare Investor Conferences
June 2, 2026
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
June 2, 2026
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
May 13, 2026
iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
May 11, 2026
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
April 8, 2026
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
April 8, 2026
1
2
Next Page
→